Zymeworks (ZYME) Enterprise Value (2021 - 2026)

Zymeworks has reported Enterprise Value for 6 years, with the latest figure at -$364.7 million in Q1 2026.

• Quarterly Enterprise Value fell 37.48% year-over-year to -$364.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$364.7 million (down 37.48% YoY) and the FY2025 annual result came in at -$228.8 million, down 1.34% from the prior year.
• Enterprise Value eased to -$364.7 million in Q1 2026 per ZYME's latest filing, from -$228.8 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$166.2 million in Q3 2022 and troughed at -$492.2 million in Q4 2022.
• A 5-year average of -$306.6 million and a median of -$297.2 million in 2024 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value plunged 94.86% in 2022, then jumped 39.68% in 2024.
• Over 5 years, Enterprise Value stood at -$492.2 million in 2022, then climbed by 23.95% to -$374.3 million in 2023, then soared by 39.68% to -$225.8 million in 2024, then retreated by 1.34% to -$228.8 million in 2025, then plunged by 59.41% to -$364.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$364.7 million, -$228.8 million, and -$251.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.